[Federal Register Volume 84, Number 226 (Friday, November 22, 2019)]
[Notices]
[Page 64544]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-25305]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; Development of Vaccines for the 
Treatment of Opioid Use Disorder.
    Date: December 11, 2019.
    Time: 8:00 a.m. to 6:30 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: The William F. Bolger Center, 9600 Newbridge Drive, 
Potomac, MD 20854.
    Contact Person: Julio C. Aliberti, Ph.D., Scientific Review 
Officer, Immunology Review Branch, Scientific Review Program, 
Division of Extramural Activities, National Institutes of Health, 
NIAID, 5601 Fishers Lane, RM 3G53A, MSC 9823, Rockville, MD 20892-
9823, 301-761-7322, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: November 15, 2019.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-25305 Filed 11-21-19; 8:45 am]
 BILLING CODE 4140-01-P